Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy

2019 ◽  
Vol 27 (7) ◽  
pp. 1145-1158 ◽  
Author(s):  
Jia Li ◽  
Wanlin Xi ◽  
Xiaofang Li ◽  
Haiying Sun ◽  
Yuyan Li
Author(s):  
Alexander Goncearenco ◽  
Minghui Li ◽  
Franco L. Simonetti ◽  
Benjamin A. Shoemaker ◽  
Anna R. Panchenko

2006 ◽  
Vol 10 (4) ◽  
pp. 583-599 ◽  
Author(s):  
Rachida S Bel Aiba ◽  
Elitsa Y Dimova ◽  
Agnes Görlach ◽  
Thomas Kietzmann

2018 ◽  
Vol 9 (7) ◽  
pp. 2008-2009
Author(s):  
George M. Burslem ◽  
Hannah F. Kyle ◽  
Adam Nelson ◽  
Thomas A. Edwards ◽  
Andrew J. Wilson

Correction for ‘Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions’ by George M. Burslem et al., Chem. Sci., 2017, 8, 4188–4202.


2005 ◽  
Vol 16 (9) ◽  
pp. 901-909 ◽  
Author(s):  
Vladimir E. Belozerov ◽  
Erwin G. Van Meir

2017 ◽  
Vol 8 (6) ◽  
pp. 4188-4202 ◽  
Author(s):  
George M. Burslem ◽  
Hannah F. Kyle ◽  
Adam Nelson ◽  
Thomas A. Edwards ◽  
Andrew J. Wilson

The state of the art in identifying protein–protein interaction inhibitors of hypoxia inducible factor – a promising target for anticancer drug design – is described.


Sign in / Sign up

Export Citation Format

Share Document